Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Rheumatology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Musculoskeletal Diseases Clinical Trials

A listing of Musculoskeletal Diseases medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (106) clinical trials

A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo And NSAID-Controlled Study To Evaluate The Efficacy And Safety Of Fasinumab In Patients With Pain Due To Osteoarthritis Of The Knee Or Hip.

Phase

Aging Frailty – Clinical Research Study

Phase N/A

A research study is evaluating an investigational medication for moderate to severe chronic lower back pain (CLBP) and osteoarthritis of the knee or hip (OA).

Phase N/A

A clinical research study is underway, evaluating an investigational study drug for adults with Parkinson's Disease who are experiencing a decline in memory and thinking.

Phase

Out-Patient Clinic in Evansville, Indiana.  NO overnight stays. Interested participant must be able to make out-patient visits to the clinic. Study drug is Tran-capsaicin injection. It is a long lasting non-opioid, derived from the chili plant, designed to provide pain relief for weeks to months after a single intra-articular injection ...

Phase

This is a Phase 3, 12-week, multi-Center, multi-national, randomized, double-blind, double-dummy, parallel-group study to determine the effectiveness, safety and tolerability of P2B001 taken once daily compared to its individual components in adults with early Parkinson's disease (PD) and to a calibration arm of Pramipexole ER. A total of 525 eligible ...

Phase

This is a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of GZ/SAR402671 in patients with early-stage Parkinson’s disease carrying a GBA mutation or other prespecified variant. The total study duration per subject in Part 2 will be approximately 168 weeks that will consist of 6.5 weeks ...

Phase

This study will assess the effectiveness of pimavanserin when given along with a selective serotonin reuptake inhibitor/selective norepinephrine reuptake inhibitor (SSRI/SNRI) for depression in adults with Parkinson’s disease.

Phase

This is a phase 1, multicenter, single-ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of a study drug (CERC-301) in adults with symptomatic Neurogenic Orthostatic Hypotension (nOH) associated with Parkinson's disease (PD).

Phase

This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a study drug (BIIB054) in adults with Parkinson’s disease (PD).

Phase